 |
|
 |
Assessing and Improving Value in Cancer Care -Potential Actions for Improvement of Existing Systems
Provided by: The Society for Translational Oncology
1. Describe the factors that can change the clinical value of a drug after the cost-effectiveness studies performed at its initial introduction into the market.
2. Describe coverage with evidence development (CED) and explain how CED may promote greater certainty regarding research conclusions regarding the value of cancer treatments and bet... |
 |
Individualized Therapy For Nonsmall-Cell Lung Cancer: A Look At Histology
Provided by: ASiM
While progress has been made with nonsmall cell lung cancer (NSCLC) therapies, maintaining quality of life, and individualizing therapy for patients based on age, performance status, comorbidities, histologic subtypes and toxicities remain the top priority for healthcare providers. Unfortunately, treating patients with NSCLC involves many discipli... |
 |
Genetics: Colon Cancer
Provided by: Harvard Medical School
Acknowledgement: This course is supported by educational grants from Celera and the Applera Charitable Foundation.
The Colon Cancer Genetics course is designed to enhance the participants' knowledge of inherited colon cancer syndromes, particularly Hereditary Nonpolyposis Colorectal Cancer (HNPCC, or Lynch Syndrome). The participant will be guid... |
 |
Radiologic and Pathologic Findings in Breast Tumors with High Signal Intensity on T2-weighted MR Images
Provided by: Radiological Society of North America
Learning Objectives: 1) List the types of breast tumors that may show high signal intensity on T2-weighted turbo SE MR images. 2) Describe the histopathologic features that produce signal hyperintensity. 3) Use the T2-weighted MR imaging appearance of breast lesions to help narrow the differential diagnosis.... |
 |
Treating Older Patients Suffering from Prostate Cancer
Provided by: American Society of Clinical Oncology
With an expanding geriatric population, it is important for cancer providers to be prepared to address the unique issues that relate to older patients. In this module, participants will explore three practical case scenarios that address issues related to the care and treatment of older patients with prostate cancer. Drs. Kathryn Bylow and Supriya ... |
 |
MANTLE CELL LYMPHOMA, PLEOMORPHIC VARIANT, INVOLVING THE BONE MARROW. Check Sample Hematology 1003-CME/CMLE
Provided by: American Society for Clinical Pathology
Upon completion of this activity, you will be able to:
* describe the typical patient with mantle cell lymphoma.
* describe the standard immunophenotype of mantle cell lymphoma.
* identify the aggressive variants of mantle cell lymphoma.
* discuss the prognostic implication of mantle cell lymphoma, blastoid and pleomorphic variants.
... |
 |
Hematology/Oncology
Provided by: Temple University School of Medicine
Educational Objectives:
At the conclusion of the course, participants should be able to:
* Improve the diagnosis and treatment of common family practice problems
* Apply traditional modes of diagnosis and management more effectively
* Apply information to commonly asked questions in office practice
* Increase proficiency an... |
 |
Medical Marijuana: Therapeutic Uses and Legal Status
Provided by: U.S. Pharmacist
After completing this activity, participants should be able to:
1. List the potential therapeutic applications of marijuana.
2. Describe the effects of marijuana on the central nervous system and other organ systems.
3. Recognize the advantages and disadvantages of synthetic cannabinoids and smoked marijuana.
4. Describe the different ... |
 |
Reporting Guidelines: FDG PET/CT In Oncology
Provided by: SNM Advancing Molecular Imaging and Therapy
Reporting Guidelines: FDG PET/CT In Oncology... |
 |
Esophageal Cancer
Provided by: CMElectures
David Loren, MD, is assistant professor of medicine at Jefferson Medical College; and director, endoscopic research at Thomas Jefferson University Hospital. Here, he discusses the clinical features of esophageal cancer, and its diagnostic modalities and staging; he also touches upon treatment options and management, and describes the unique relatio... |
 |
Insights into Pain Management - Module 6: Use and Abuse of Opioid Analgesics
Provided by: University of Pennsylvania School of Medicine
Insights into Pain Management -
Module 6: Use and Abuse of Opioid Analgesics
Faculty: Rollin M. Gallagher, MD, MPH
Director of Pain Management
Department of Anesthesiology
Philadelphia VA Medical Center
Philadelphia, Pennsylvania
Estimated Time to Complete: 1 hour
Credit: Up to 1 AMA PRA Category 1 Credit™
Fee: No charge
Original... |
|
Insights into Pain Management - Module 4: Understanding Chronic Pain
Provided by: University of Pennsylvania School of Medicine
Insights into Pain Management -
Module 4: Understanding Chronic Pain
Faculty: Scott M. Fishman, MD
Professor of Anesthesiology and Pain Medicine
Chief, Division of Pain Medicine
University of California Davis Health System
Sacramento, California
Estimated Time to Complete: 1 hour
Credit: Up to 1 AMA PRA Category 1 Credit™
Fee: No cha... |
 |
Exciting New Advances in Neuro-Oncology: The Avenue to a Cure for Malignant Glioma
Provided by: American Cancer Society
After completing this activity, the learner should be able to:
* Discuss recent discoveries in the biology of malignant gliomas that are of greatest therapeutic relevance.
* Summarize the concepts and application of emerging technologies in the surgical and radiotherapeutic management of malignant gliomas.
The American Cancer Society (... |
|
Tumors of the Lung, Pleura and Mediastinum
Provided by: CMElectures
John M. Travaline, MD, is an associate professor of medicine and an associate professor of pathology and laboratory medicine at Temple University School of Medicine. He is also the director of the Lung Cancer program at the Temple Lung Cancer Center and director of pulmonary invasive procedures at Temple University Hospital. Here, he discusses the ... |
 |
Pneumonectomy is a valuable treatment option after neoadjuvant therapy for stage III non-small-cell lung cancer
Provided by: American Association for Thoracic Surgery
After reading this article, the learner should be able to:
* Understand the impact of previous neoadjuvant therapy on survival of stage III non-small cell lung cancer following pneumonectomy.
* Identify the various predictors of survival after neoadjuvant therapy and pneumonectomy based on univariate and multivariate analysis from this stud... |
 |
Pain Management: Cancer Pain and Pain at the End of Life
Provided by: Wild Iris Medical Education
The purpose of this course is to give an overview of the management of the pain caused by cancer and experienced at the end of life.
Upon completion of this course, you will be able to:
* Summarize the types and causes of cancer pain and its treatment.
* Discuss management of the pain caused by cancer and its treatment.
* Evaluate ethical pri... |
|
Clear Cell Papillary Renal Cell Carcinoma and the Differential Diagnosis of Renal Neoplasms With Clear Cytoplasm and Papillary Architecture . Check Sample Surgical Pathology II 1008-CME
Provided by: American Society for Clinical Pathology
Upon completion of this activity, you will be able to:
* describe the renal neoplasms that may have papillary and/or cystic architecture with clear cell cytology.
* recognize the histopathologic features of clear cell papillary renal cell carcinoma.
* interpret the immunohistochemical profile of renal neoplasms with components of papillar... |
 |
Microtubule-Targeting Agents: Old, New, and Emerging Roles
Provided by: myCME.com
An update on evolving developments related to microtubule-inhibiting agents and their role in the treatment of women with metastatic or locally advanced breast cancer. Highlights include: an examination of the rationale for microtubule inhibition, including treatment challenges in resistant or refractory breast cancer; a discussion of the clinical ... |
 |
Targeting Cervical Cancer with the HPV Vaccines
Provided by: American Society for Colposcopy & Cervical Pathology
A quadrivalent human papillomavirus (HPV) vaccine has been available since 2006 offering protection against HPV types 6, 11, 16, and 18. In October 2009, the U.S. Food and Drug Administration approved a second, bivalent, vaccine against HPV types 16 and 18. HPV types 16 and 18 are known to be the etiologic agent in approximately two-thirds to three... |
 |
The Spectrum of Vascularized Superficial Soft-Tissue Tumors on Sonography With a Histopathologic Correlation: Part 1, Benign Tumors
Provided by: American Roentgen Ray Society
Peer-reviewed articles from American Journal of Roentgenology (AJR). This activity offers AMA PRA Category 1 Credit(s)(TM) following completion of an online test.... |
 |
Autophagy in Cancer
Provided by: University of California, Davis, Health System
Forms
CME Credit Application and Disclosure
Accreditation
The UC Davis Health System is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. This CME activity was planned in accordance with the ACCME essentials for enduring materials. Length of time has been ... |
|
Spectrum of Vascularized Superficial Soft-Tissue Tumors on Sonography With a Histopathologic Correlation: Part 2, Malignant Tumors & Their Look-Alikes
Provided by: American Roentgen Ray Society
Peer-reviewed articles from American Journal of Roentgenology (AJR). This activity offers AMA PRA Category 1 Credit(s)(TM) following completion of an online test.... |
|
The Role of Surgery and Radiation Therapy in the Management of Gestational Trophoblastic Disease
Provided by: The Society for Translational Oncology
1. Describe the indications for surgical intervention in the management of patients with hydatidiform moles and malignant GTN in order to choose patients most likely to benefit from these interventions.
2. Discuss the use of radiation in the management of patients with malignant GTN and consider its use as an adjunct to chemotherapy or surge... |
 |
Neuroblastoma
Provided by: Institute for Advanced Medical Education
Course: Neuroblastoma
Target Audience: Physicians, sonographers and others who perform and/or interpret OB ultrasound.
System requirements: In order to complete this program you must have a computer with a recent version of Internet Explorer or Netscape, and a printer, which is configured to print from the browser. You will need Acrobat Reade... |
|
Malignant Lesions of the Head and Neck 1
Provided by: CMElectures
Robert T. Sataloff, MD, is a professor of otolaryngology, head and neck surgery at Jefferson Medical College and an adjunct professor of otorhinolaryngology at the University of Pennsylvania. Here, he discusses the prevalence and risk factors for primary malignant neoplasms of the head and neck, the principles of diagnoses and the current guideline... |
|
Mucosal Melanomas: A Case-Based Review of the Literature
Provided by: The Society for Translational Oncology
1. Differentiate mucosal melanoma from cutaneous melanoma and describe its etiology, molecular features, and treatment approaches in surgical, radiation, and medical oncology.
2. Evaluate mucosal melanoma patients with non-metastatic disease for adjuvant radiation to optimize treatment of the primary tumor.
3. Refer appropriate patients ... |
|
Metastatic Case Studies in Prostate, Breast, Colorectal, and Lung Cancer
Provided by: Harvard Medical School
Acknowledgement: We wish to gratefully acknowledge an educational grant from Sanofi Aventis for this course.
The cases will include differential diagnoses, pathogeneses, and treatment approaches and will illustrate the role of the primary care provider and the oncologist in the management of this disease. Prostate, colorectal, breast, and lung c... |
|
ASCO Tumor Boards: Pancreatic
Provided by: American Society of Clinical Oncology
Learning Objectives:
* Incorporate the use of radiotherapy, when appropriate, as treatment for patients with pancreatic cancer.
* Asses systemic therapy options for patients with advanced and metastatic disease.
* Enhance awareness of novel targets and emerging therapies which may be appropriate as front-line therapy options.
* Apply knowledge ... |
 |
Health Issues Distinctive to Women
Provided by: NetCE
Demographic changes, the rapid increase in the number of aging and minority women, new pharmacological treatments for breast cancer and osteoporosis, and the increased demand for complementary therapies are just a few of the issues surrounding women's health. This course includes health promotion and preventative screening recommendations, diagnost... |
|
Targeted First-Line Therapy for Advanced Non-Small Cell Lung Cancer: Inhibitory Pathways That Signal Better Survival and Overall Outcomes
Provided by: myCME.com
Treatment for non-small cell lung cancer (NSCLC) had previously relied on one-size-fits-all therapies. Now treatment approaches based on personalized medicine, targeted therapies, and tumor histologies represent a significant advance in the treatment of NSCLC. A multidisciplinary roundtable of expert panelists discusses recent evidence and areas of... |
|
|
Virtual Exhibits / Booths
Join Email List
Visit Our Website
